Medical Device Investing Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
Medical Device Investing Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medical Device Investing Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Medical Device Investing Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse Technology
Medical Device Investing Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Medical Device Investing Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
Medical Device Investing Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
Medical Device Investing Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Medical Device Investing Pulse Biosciences Announces Clinical Data Highlighting its nPulse Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Medical Device Investing Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation
Medical Device Investing Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635
Medical Device Investing Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule Study
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
